Description

1-(4-Fluorophenyl)-1,3,8-Triazaspiro[4.5]Decan-4-One is a high-purity, advanced pharmaceutical intermediate featuring a unique spirocyclic triaza structure. This compound is of significant value for medicinal chemistry research and development, particularly in the synthesis of novel therapeutic agents. It is primarily sought after by R&D teams and manufacturers in the pharmaceutical, biotechnology, and fine chemical sectors for constructing complex molecular architectures.

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of new drug candidates, especially those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization due to its spirocyclic scaffold and fluorine substituent.
• Biochemical Tool Compound: Serves as a precursor or reference standard in the development of enzyme inhibitors or receptor modulators for biological testing.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses requiring a complex, functionalized heterocyclic core.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for client projects.
• Academic Research: Utilized in university and institutional labs for exploratory chemistry and the development of new synthetic methodologies.

Basic Information

Product Name	1-(4-Fluorophenyl)-1,3,8-Triazaspiro[4.5]Decan-4-One
CAS No.	58012-16-1
Molecular Formula	C14H17FN4O
Molecular Weight	276.31 g/mol
Synonyms	1-(4-Fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one; 8-(4-Fluorobenzyl)-1,3,8-triazaspiro[4.5]decan-4-one; 1,3,8-Triazaspiro[4.5]decan-4-one, 1-(4-fluorophenyl)-; 58012-16-1; FC-1019 (Potential Research Code); Spiro[4.5]decan-4-one, 1-(4-fluorophenyl)-1,3,8-triaza-
EINECS	Contact for details

Quality Control

Our 1-(4-Fluorophenyl)-1,3,8-Triazaspiro[4.5]Decan-4-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications and test results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere for long-term storage.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.